Search Results

You are looking at 61 - 70 of 89 items for :

  • Medical and Health Sciences x
  • Refine by Access: All Content x
Clear All

%) Ayahuasca 4 (2%) 5-HT-2A research chemicals 3 (1%) Drug History LSD 174 (80%) Psilocybin 154 (71%) MDMA 38 (17%) DMT 29 (13%) Mescaline 28 (13%) Ayahuasca 5 (2%) 5-HT-2A research chemicals 12 (6%) Note . N represents the sum total number of participants who

Open access

, Reed, and Aggarwal ( 2019 ) describe culturally informed research design and treatment issues, with respect to a 3,4-methylenedioxy-methamphetamine (MDMA)-assisted psychotherapy study for post-traumatic stress disorder (PTSD) at a university medical

Open access
Orvosi Hetilap
Authors:
Katalin Kovács
,
Anita Réka Tóth
, and
Éva Margit Kereszty

150 155 Sano, R., Hasuike, T., Nakano, M., et al.: A fatal case of myocardial damage due to misuse of the “designer drug” MDMA. Leg. Med. (Tokyo), 2009, 11 , 294

Restricted access

suggested to be beneficial in the treatment of substance-use disorders ( dos Santos et al., 2016 ; Krebs & Johansen, 2012 ). Similarly, 3,4,-methylenedioxymethamphetamine (MDMA) has been shown to be efficacious as an adjunct to psychotherapy in the

Open access

0 Gouzoulis-Mayfrank, E., Hermle, L., Kovar, K. A. és mtsa: Die Entaktogene “Ecstasy” (MDMA), “Eve” (MDE) und andere ringsubstituirte

Restricted access

: psilocybin in the treatment of depressive disorders and 3,4-methylenedioxymethamphetamine (MDMA) in the treatment of post-traumatic stress disorder (PTSD; For the purposes of this commentary, MDMA is considered a psychedelic – not only as a cultural or a

Open access

.1080/02791072.2015.1094156 Buffum , J. , & Moser , C. ( 1986 ). MDMA and human sexual function . Journal of Psychoactive Drugs, 18 ( 4 ), 355 – 359 . doi: 10.1080/02791072.1986.10472369 10

Open access

occasionally, a few times per year”) and 3,4-methylenedioxymethamphetamine (MDMA or ecstasy ) (“occasionally, but for a year I have used it several times, every 2–3 months, in the weekends”), and had been a daily cannabis smoker for the preceding 8 years. Ms

Open access

) analysis, he found that African Americans report unique motivations for using MDMA. However, he concedes that these results, obtained from a small, low socioeconomic (SES) sample, may not be representative. In his recommendations for further research, Rigg

Open access

psychedelic substances for the treatment of psychological disorders. This has included the administration of a range of substances, including LSD, psilocybin, ayahuasca, methylenedioxymethamphetamine (MDMA), and ibogaine, in conjunction with psychotherapy for

Open access